Expansion of HIV-specific CD4+ and CD8+ T cells by dendritic cells transfected with mRNA encoding cytoplasm- or lysosome-targeted Nef
/in HIV/AIDS, International PublicationsHPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities
/in Cervical Cancer, Dendritic Cells, International PublicationsEndocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions
/in HIV/AIDS, International PublicationsDendritic cells expand Epstein Barr virus specific CD8+ T cell responses more efficiently than EBV transformed B cells
/in International Publications, Malignant LymphomaImmunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patients
/in International Publications, Prostate CancerSynergistic interaction of hyperthermia and Gemcitabine in lung cancer
/in International Publications, NSCLCA mechanism of hyperthermia-induced apoptosis in ras-transformed lung cells
/in International Publications, NSCLCNatural killer cells in hepatitis C virus infection: from innate immunity to adaptive immunity
/in Chronic Virus Hepatitis, International PublicationsNatural killer-dendritic cell cross-talk in cancer immunotherapy
/in Dendritic Cells, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer